David Buxton, MD
David Buxton, MD
Chair, Department of Supportive Care Medicine
Program: Supportive Care Medicine
Research Program: Health Outcomes & Behavior Program
-
Overview
His research is focused on novel psychedelic medications including Ketamine Assisted Psychotherapy for cancer patients.
Associations
- Supportive Care Medicine
- Health Outcomes & Behavior Program
-
Research Interest
Bereavement therapy through the use of psychedelic psychotherapy; Communication methods to open dialogue of 'unmentionables' in healthcare; Palliative medicine consultation effects on financial impact for hospitals and systems
-
Publications
- Chammas D, Moment A, Leff V, Buxton D, Rosa WE, Brenner K. Top Ten Tips Palliative Care Clinicians Should Know About Supporting Coping in Serious Illness. J Palliat Med. 2025 May. Pubmedid: 40405812.
- Cassel JB, McClish D, Buxton D, Yanni L, Roberts S, Skoro N, May P, Del Fabbro E, Noreika D. Specialty palliative care use among cancer patients: A population-based study. PLoS One. 2025 Jan.20(1):e0313732. Pubmedid: 39804856. Pmcid: PMC11730419.